Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Picard Medical (PMI) Change in Inventory (2024 - 2026)

Picard Medical posted quarterly Change in Inventory of $321000.0 for Q1 2026, up 30.49% year-on-year from $246000.0 in Q1 2025, and down 39.55% on a QoQ basis from $531000.0 in Q4 2025.

Picard Medical (PMI) has 3 years of Change in Inventory data on file, last reported at $321000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Change in Inventory rose 30.49% year-over-year to $321000.0; the trailing twelve-month figure through Mar 2026 stood at -$315000.0 (changed N/A YoY), and the FY2025 full-year result was -$390000.0, down 129.32% from the prior year.
  • Change in Inventory for Q1 2026 stood at $321000.0, down from $531000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $648000.0 in Q3 2024 and bottomed at -$901000.0 in Q2 2025.
  • The 3-year median for Change in Inventory is $246000.0 (2025), against an average of $44714.3.
  • Peak annual rise in Change in Inventory reached 299.62% in 2025, while the deepest fall reached 141.05% in 2025.
  • A 3-year view of Change in Inventory shows it stood at -$266000.0 in 2024, then surged by 299.62% to $531000.0 in 2025, then sank by 39.55% to $321000.0 in 2026.
  • The last three Change in Inventory figures came in at $321000.0 (Q1 2026), $531000.0 (Q4 2025), and -$266000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 420.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 127.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 131.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 177.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 1.60 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -264.59 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 65.20 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 171.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -38.50 Mn
10 Picard Medical 12.10 Mn 12.10 Mn 275,000.00 321,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 321,000.00
Mar 31, 2026 321,000.00
Dec 31, 2025 531,000.00
Dec 31, 2025 531,000.00
Sep 30, 2025 -266,000.00
Sep 30, 2025 -266,000.00
Dec 31, 2024 -266,000.00
Dec 31, 2024 -266,000.00
Sep 30, 2024 648,000.00
Sep 30, 2024 648,000.00